Gastric mucus layer and mucosal surface components

The gastric mucus layer and mucosal surface components constitute a complex physiological barrier essential for protecting the stomach lining from the corrosive effects of hydrochloric acid and pepsin (StatPearls, "Physiology, Gastric Barrier"). This barrier primarily consists of a gel-like layer of mucins, specifically MUC5AC and MUC6, along with bicarbonate ions and phospholipids that maintain a pH gradient across the epithelium (PubMed, PMID: 22109243). In addition to physical protection, these components facilitate lubrication and provide a niche for beneficial microbiota while trapping pathogens. Dysregulation or depletion of this layer is a hallmark of diseases such as peptic ulcer disease, gastritis, and NSAID-induced mucosal injury (NIH, "Gastritis"). Therapeutic intervention often involves cytoprotective agents like sucralfate or misoprostol that either physically reinforce the mucus layer or stimulate the endogenous production of its components through prostaglandin-mediated pathways (DrugBank, DB00364). These drugs are particularly effective in preventing damage from exogenous irritants and promoting the healing of the underlying gastric epithelium. Understanding the integrity of this barrier is crucial for developing treatments that enhance gastric mucosal defense and promote healing of existing lesions.

Other names

Gastric mucosal barrierGastric mucus-bicarbonate barrierGastric surface mucusGastric mucus gel layer

Drugs targeting this system work by forming a physical protective paste over ulcerated tissue (e.g., sucralfate), stimulating the secretion of mucus and bicarbonate (e.g., rebamipide), or increasing local prostaglandin levels to enhance mucosal blood flow and barrier integrity (e.g., misoprostol) (FDA Label, Carafate; PubMed, PMID: 15671470).